Compounded Aseptic Medicines
This Framework Agreement is for the supply of unlicensed, aseptically compounded, ready to use medicines in syringe and infusion bags to NHS Scotland. The Goods have been separated into four (4) categories, each of which is identified as a “Lot”. Full details of each Lot is contained in section II.2 of this notice.
Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Value
£74,200,000
Published
25 Sept 2019
Closes
28 Oct 2019
Procurement details
Source
Pcs
Region
United Kingdom
Procurement method
Open
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
Lots
Lot 1 Compounded Aseptic Medicines
£26,800,000
Supply of the following aseptically compounded, ready to use medicines in syringes and infusions to NHS Scotland in a range of doses, Atezolizumab Cetuximab Doxorubicin Epirubicin Infliximab (Inflectra®), (Remicade®), (Remsima®) Nivolumab Pembrolizumab Pertuzumab The Authority intends awarding all presentations within this Lot to a single supplier. Full deta...
Delivery: United Kingdom
Lot 2 Compounded Aseptic Medicines
£16,300,000
Supply of the following aseptically compounded, ready to use medicines in syringes and infusions to NHS Scotland in a range of doses, Cyclophosphamide Fluorouracil Irinotecan Methotrexate Rituximab (Mabthera®), (Rixathon®), (Truxima®) The Authority intends awarding all presentations within this Lot to a single supplier. Full details of Goods and volumes can...
Delivery: Scotland
Lot 3 Compounded Aseptic Medicines
£8,100,000
Supply of the following aseptically compounded, ready to use medicines in syringes and infusions to NHS Scotland in a range of doses, Bortezomib Carboplatin Cisplatin Docetaxel Gemcitabine Oxaliplatin Trastuzumab (Herceptin®), (Herzuma®) Vincristine The Authority intends awarding all presentations within this Lot to a single supplier. Full details of Goods a...
Delivery: Scotland
Lot 4 All Other Presentations
£23,000,000
Supply of the following aseptically compounded, ready to use medicines in syringes and infusions to NHS Scotland in a range of doses, The molecules included in this Lot are, Bevacizumab Cytarabine Infliximab (Zessly®) Insulin Methotrexate Natalizumab Nivolumab Paclitaxel Pemetrexed Tocilizumab Trastuzumab (Kanjinti®), (Ontruzant®) Trastuzumab Subcutaneous Ve...
Delivery: United Kingdom
Documents
Unlock document linkCompounded Aseptic Medicines
Not provided
This Framework Agreement is for the supply of unlicensed, aseptically compounded, ready to use medicines in syringe and infusion bags to NHS Scotland. The Goods have been separated into four (4) categories, each of which is identified as a...
Contract notice · Web page
Compounded Aseptic Medicines
Not provided
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.